video

Cortex Expands with Re-invention of Historic 4340 Duncan Building

The $44 million, 15-month renovation of 4340 Duncan in the Cortex Innovation District is nearly complete, and demonstrates the connection, collaboration and community partnership...

The Ag Innovation Showcase looks to the Future of Farming and Food

The St. Louis Danforth Plant Center brings together innovators from all walks of the agricultural industry to address the farming's greatest challenges and opportunities.

With Help From The Yield Lab, Aptimmune Biologics Gains Access to the Worldwide Market

Aptimmune Biologics, a member of the 2016 Yield Lab portfolio of AgTech startups, announced their partnership with Kemin Industries, an Ag and Animal product...

St. Louis Has “Agglomeration” In AgTech, According To A Brookings Report, And That’s A...

A report from the Brookings Institution looks at regional economic strategies surrounding industry clusters, and highlights the work of BioSTL, the Donald Danforth Plant Science Center, and the St. Louis Economic Development Partnership, as examples of organizations that are currently getting it right.
Saturn Agroscience

AgTech Pioneer Benson Hill Biosystems Launches New Subsidiary

St. Louis-based Benson Hill Biosystems, a crop improvement AgTech company unlocking the natural genetic potential of plants, announced the formation of Saturn Agrosciences, a...
BioGenerator

Local Immunotherapy Startup Attracts $3 Million Investment

BioGenerator-supported Company to Advance Cancer Therapies.

SentiAR Scored A Major Milestone In Federal Grant Peer Review Process

SentiAR, an augmented reality startup based in St. Louis, recently completed a rigorous peer-review panel that ended with a stellar score – and a $2.2M grant. SentiAR's success shows that the medical world is ready for AR, and their startup story shows what's possible when a city shares your vision.

St Louis Startup Boom Was 20 Years In The Making

"St Louis is really doing it! St Louis has more plant scientists than anywhere else in the world - I think people would be shocked to hear that."

How Confluence Acquisition Will Work For Aclaris In St. Louis

Yesterday, BioGenerator's first co-working lab tenant, Confluence Life Sciences, got acquired by Aclaris Therapeutics, Inc at a valuation of $100MM.On the acquisition, Confluence's...

St Louis Bioscience Startup Acquired at $100 Million Valuation

Confluence Life Sciences, the first company incubated at BioGenerator's co-working lab at Cortex, has been acquired by Aclaris Therapeutics.

GlobalSTL Attracts International Healthcare Innovators by Focusing in on St. Louis Strengths

Thirteen Israeli and Irish companies are working to launch business deals with St. Louis healthcare systems and corporations following the inaugural GlobalSTL Health Innovation Summit.

Meet Bill Schmidt: Managing Partner at Cultivation Capital Life Sciences Fund

As Managing Partner of the Life Sciences Fund at Cultivation Capital, Bill Schmidt is currently focused on the venture capital firm's Life Sciences Fund II. He's dedicated to helping life sciences entrepreneurs take their companies to the next level–and the good news for founders is, he's done it himself. We sat down with Schmidt to hear how he got his start as a founder, and now investor, in St. Louis.
Chris Danforth

Meet Chris Danforth: General Partner Cultivation Capital Life Sciences Fund

Chris Danforth has his hand in a wide variety Life Sciences investment and non-profit activity throughout the region. Meet the general partner in St. Louis-based venture firm Cultivation Capital's Life Sciences Fund and Managing Director of The Yield Lab.
Dollar sign fundraising

12 Fundraising Tips for BioTech companies from Cultivation Capital’s Life Sciences Fund

Bill Schmidt, Managing Partner of Cultivation Capital's Life Science Fund, shares tips for BioTech companies focused on fundraising.
Automation team GlobalSTL

From Israel to Ireland: Checking in With GlobalSTL

The initiative can now boast five international startup companies that have chosen St. Louis for their US base. Here's a look at some of their success stories.
Adarza BioSystems

Adarza BioSystems Closes on $17 Million – What’s Next for the Life Science Startup

On January 19, startup Adarza BioSystems, Inc, based in St. Louis and Rochester, New York, closed on $17 Million in Series C financing. Here's what the life science company is focused on next.
BioGenerator

Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

Since its inception in 2013, Cultivation Capital’s Life Sciences Fund’s portfolio of 14 companies and one accelerator have raised $321M in total funding–with a...

How Sling Health Grew from a Washington University Organization to a National Model

In January 2013, their second year of the M.D.-Ph.D. program in biomedical engineering at Washington University, Stephen Linderman and his classmates made two critical...

The Society of Physician Entrepreneurs Launches St. Louis Chapter

A St. Louis chapter of The Society of Physician Entrepreneurs (SoPE)—a global organization that fosters healthcare, life science and biomedical innovation— was recently launched...

Founder Series: Steven Hanley of MediBeacon

MediBeacon is a name to know in the STL BioTech sector. The makers of proprietary, non-invasive, real-time monitoring systems for kidney function, gastrointestinal permeability...
appistry managed services

Appistry Launches Managed Services for Clinical Laboratories

The new managed services will help clinical laboratories establish and expand next-generation sequencing based testing capabilities.

4 Key Findings from Express Scripts’ 2015 Drug Trend Report and What All Entrepreneurs...

As the largest pharmacy benefit management organization in the United States, St. Louis-based Express Scripts sits in the perfect position to survey the pharmaceutical...

Climate Change: The Yield Lab’s Answer to the Standard Accelerator Model

The right climate is crucial for growth. The Yield Lab knows that’s as true for agriculture as it is for startups. By identifying promising...

Founder Series: Blake Marggraff of Epharmix

Blake Marggraff is a name you probably already know. He launched his first company in just his second year in college, later receiving an Arch...
BioGenerator Lab

Breaking Down BioGenerator

What is BioGenerator?  The short answer: A subsidiary of the non-profit organization BioSTL that was formed in 2003 to create, grow and invest in life...

How Express Scripts Fosters a Culture of Innovation

A national leader in the prescription medication industry, Express Scripts has stayed ahead of the curve by focusing on innovation and using data to...

Tomas Pena of S4 Finds a Home Away From Home in St. Louis

St. Louis is in the heart of the Corn Belt. It’s a perfect seat for AgTech companies looking to serve the U.S. market, and...

Veniti’s CFO Catherine Matthes on Clinical Trial Funding

The veins in your body play an integral role in circulation: carrying blood from the different parts of your body back to your heart. But as...

How Arch Grant’s Recipient Hemadvance Attracted its Startup Dream Team

As the leading cause of mortality in the world—responsible for more than 30 percent of global deaths according to the World Health Organization—the magnitude...

BioGenerator Company Accuronix Targets Pancreatic Cancer

Pancreatic Cancer causes 40,000 deaths each year, with available chemotherapy regimens providing only an average of 6-11 months survival. WashU-born company Accuronix, founded by...

Robert Beardsley on Galera Therapeutics’ High Growth

As of February 2016, Galera Therapeutics, Inc., a drug development company based in Greater Philadelphia,  had raised $42 million in Series B financing for the...
Cultivation Capital EQ Life Science

Life Sciences in St. Louis: Q/A with Rick Ryan, General Partner of Cultivation Capital

What's happening in the Life Sciences sector and where is it headed next? We sat down with Rick Ryan to find out.Rick Ryan is...

That’s Life (Sciences)

We examine St. Louis' life sciences startup scene: a hotbed of innovation, growth and promise.

Yield Lab Announces 2016 Portfolio Companies

More than 120 applications from 26 countries were submitted for the seven spots in Yield Lab’s 2016 class. The nation’s first and largest agriculture...

How APSE Aims to Change AgTech

John Killmer brings more than 30 years of experience working in Agtech from serving as President of Monsanto China to now acting as CEO...

Why (And How) You Should Use BioSTL’s Roadmap to Entrepreneurship

Entering the startup space can be intimidating, no matter what your area of expertise or interest is in. For those in the life science...

John Talley Takes on Cancer with Euclises Pharmaceuticals

St. Louis' Euclises Pharmaceuticals, co-founded by renowned drug discoverer John Talley, aims to take on colorectal cancer, the third most common type of the disease in the U.S.

Why All Wine Drinkers Will Love StiQit™

We spoke with Alan MacInnes of YourBevCo about StiQit, and how it will impact all wine drinkers.

STL-based Immunophotonics is taking on cancer using your own body

What Immunophotonics is working on is a therapeutic vaccine designed to pull back the curtain on cancer, and train the body to see through the disguise.

Why This Year’s Ag Innovation Showcase Is A Big Deal For Startups And St....

We've teamed up with BioSTL and The Yield Lab to offer you an even closer look at what the Ag Innovation Showcase has in store.

Intel: Inside the St. Louis-Israel Innovation Connection

Israel has a wealth of innovation-based startups that are already based in industries that have a stronghold in St. Louis.

Can St. Louis Become the Next Bioscience Hub?

The growing list of bioscience companies bringing their research and operations to STL has forced many to take notice of the city's place in the industry's evolving landscape

Latest Stories

Popular Stories